Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0B9CA
|
|||
| Former ID |
DIB008843
|
|||
| Drug Name |
Tuvirumab
|
|||
| Synonyms |
Ostavir; Hepatitis B MAb, Corange; Hepatitis B MAb, PDL; OST-577; Human anti-HBV, PDL; SDZ-OST-577; Anti-HBV MAb (humanized), Protein Design Labs; Anti-HBV, PDL/Corange
Click to Show/Hide
|
|||
| Drug Type |
Monoclonal antibody
|
|||
| Indication | Hepatitis B virus infection [ICD-11: 1E51.0; ICD-10: B18.1] | Terminated | [1] | |
| Company |
Novartis AG
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800002864) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.